English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Our Portfolio
    • Overview
    • Canadian Product Portfolio
    • US Product Portfolio
  • News
    • Press Releases
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentation
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR
  • Contact
  • Careers
  • English
  • Français

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    • 2022 Annual Meeting
    • 2021 Annual Meeting
    • 2020 Annual Meeting
    • 2021 Special Meeting
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Presentation
  • Financial Results
  • Stock Data
    • TSX: MDP
    • OTCQX: MEDXF
    • Analyst Coverage
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • SEDAR
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
  • 2022 Annual Meeting
  • 2021 Annual Meeting
  • 2020 Annual Meeting
  • 2021 Special Meeting
May 07, 2020 5:00pm EDT

Medexus Announces US$20 Million Asset-Based Credit Facility and Repays US$10 Million of its Term Loan

Apr 08, 2020 8:30am EDT

Medexus Reports Triamcinolone Hexacetonide Injectable Suspension Approved for Public Reimbursement in Canada

Mar 23, 2020 1:24pm EDT

Medexus to Present at the Spring Investor Summit on March 25th

Mar 23, 2020 8:30am EDT

Medexus Provides a Business Update and Outlines Response to COVID-19 Pandemic

Feb 28, 2020 8:59am EST

Medexus Expands its US Product Portfolio by Acquiring the Hematology Asset IXINITY®

Feb 18, 2020 6:52pm EST

Medexus Pharmaceuticals Reports Revenue of $16.2 Million for the Third Quarter of Fiscal 2020

Feb 12, 2020 8:30am EST

Medexus Pharmaceuticals Schedules Third Quarter Fiscal 2020 Conference Call

Nov 29, 2019 5:00pm EST

Medexus Pharmaceuticals Reports Operating and Financial Results for the Second Quarter of Fiscal 2020

Nov 25, 2019 9:22am EST

Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2020 Conference Call

Nov 19, 2019 8:30am EST

Medexus Granted Priority Review Status for Gliolan® by Health Canada

RSS
  • Previous
    • 1...
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Medexus Pharmaceuticals, Inc.
    All Rights Reserved.
    Facebook Facebook
    Privacy Policy Disclaimer Sitemap

    Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.